Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/35540
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMuhi, Stephen-
dc.contributor.authorMarshall, Julia L-
dc.contributor.authorO'Brien, Daniel P-
dc.contributor.authorJohnson, Paul D R-
dc.contributor.authorRoss, Gayle-
dc.contributor.authorRamakrishnan, Anand-
dc.contributor.authorMackay, Laura K-
dc.contributor.authorDoerflinger, Marcel-
dc.contributor.authorMcCarthy, James S-
dc.contributor.authorJamrozik, Euzebiusz-
dc.contributor.authorOsowicki, Joshua-
dc.contributor.authorStinear, Timothy P-
dc.date2024-
dc.date.accessioned2024-10-21T03:53:54Z-
dc.date.available2024-10-21T03:53:54Z-
dc.date.issued2024-
dc.identifier.citationWellcome Open Research 2024; 9en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/35540-
dc.description.abstractCritical knowledge gaps have impeded progress towards reducing the global burden of disease due to Mycobacterium ulcerans, the cause of the neglected tropical disease Buruli ulcer (BU). Development of a controlled human infection model of BU has been proposed as an experimental platform to explore host-pathogen interactions and evaluate tools for prevention, diagnosis, and treatment. We have previously introduced the use case for a new human model and identified M. ulcerans JKD8049 as a suitable challenge strain. Here, we present a provisional protocol for an initial study, for transparent peer review during the earliest stages of protocol development. Following simultaneous scientific peer review and community/stakeholder consultation of this provisional protocol, we aim to present a refined protocol for institutional review board (IRB) evaluation.en_US
dc.language.isoeng-
dc.subjectBairnsdale ulceren_US
dc.subjectBuruli ulceren_US
dc.subjectM. ulceransen_US
dc.subjectMycobacterium ulceransen_US
dc.subjectcontrolled human infection modelen_US
dc.titleA human model of Buruli ulcer: Provisional protocol for a Mycobacterium ulcerans controlled human infection study.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleWellcome Open Researchen_US
dc.identifier.affiliationDepartment of Microbiology and Immunology, Doherty Institute, University of Melbourne, Melbourne, Victoria, 3000, Australia.;Victorian Infectious Diseases Service, The Royal Melbourne Hospital, Parkville, Victoria, Australia.;Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.;Department of General Medicine, The Royal Melbourne Hospital, Parkville, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Infectious Diseases, Doherty Institute, University of Melbourne, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationVictorian Infectious Diseases Service, The Royal Melbourne Hospital, Parkville, Victoria, Australia.;Department of Infectious Diseases, Doherty Institute, University of Melbourne, Melbourne, Victoria, Australia.;Department of Infectious Diseases, Barwon Health, Geelong, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Microbiology and Immunology, Doherty Institute, University of Melbourne, Melbourne, Victoria, 3000, Australia.;Austin Health, Heidelberg, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Dermatology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Plastic and Reconstructive Surgery, The Royal Melbourne Hospital, Parkville, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Microbiology and Immunology, Doherty Institute, University of Melbourne, Melbourne, Victoria, 3000, Australia.en_US
dc.identifier.affiliationWalter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.;Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.en_US
dc.identifier.affiliationVictorian Infectious Diseases Service, The Royal Melbourne Hospital, Parkville, Victoria, Australia.;Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.;Department of Infectious Diseases, Doherty Institute, University of Melbourne, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of General Medicine, The Royal Melbourne Hospital, Parkville, Victoria, Australia.;WHO Collaborating Centre for Bioethics, Monash University, Clayton, Victoria, Australia.en_US
dc.identifier.affiliationTropical Diseases Research Group, Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, Victoria, Australia.;Infectious Diseases Unit, Department of General Medicine, The Royal Children's Hospital, Parkville, Victoria, Australia.;Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Microbiology and Immunology, Doherty Institute, University of Melbourne, Melbourne, Victoria, 3000, Australia.;WHO Collaborating Centre for Mycobacterium ulcerans, Doherty Institute, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationThe Peter Doherty Instituteen_US
dc.identifier.doi10.12688/wellcomeopenres.22719.1en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0001-9873-7163en_US
dc.identifier.orcid0000-0001-5750-1920en_US
dc.identifier.orcid0000-0001-5540-8124en_US
dc.identifier.orcid0000-0001-6596-9718en_US
dc.identifier.orcid0000-0001-5940-602Xen_US
dc.identifier.orcid0000-0002-9432-6700en_US
dc.identifier.orcid0000-0003-0150-123Xen_US
dc.identifier.pubmedid39386965-
dc.description.volume9-
dc.description.startpage488-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
crisitem.author.deptInfectious Diseases-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

14
checked on Dec 23, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.